ŞEKERCİ, Ç. A. Et Al. 2017. 476 - The Value of Urinary BDNF Levels on Assessment of The Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia. 32nd Annual EAU Congress , (Londrina, Brazil), 823-824.

ŞEKERCİ, Ç. A., TANIDIR, Y., TOP, T., İŞBİLEN BAŞOK, B., İŞMAN, F. K., ŞİMŞEK, F., ... AKBAL, C.(2017). 476 - The Value of Urinary BDNF Levels on Assessment of The Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia . 32nd Annual EAU Congress (pp.823-824). Londrina, Brazil

ŞEKERCİ, ÇAĞRI Et Al. "476 - The Value of Urinary BDNF Levels on Assessment of The Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia," 32nd Annual EAU Congress, Londrina, Brazil, 2017

ŞEKERCİ, ÇAĞRI A. Et Al. "476 - The Value of Urinary BDNF Levels on Assessment of The Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia." 32nd Annual EAU Congress , Londrina, Brazil, pp.823-824, 2017

ŞEKERCİ, Ç. A. Et Al. (2017) . "476 - The Value of Urinary BDNF Levels on Assessment of The Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia." 32nd Annual EAU Congress , Londrina, Brazil, pp.823-824.

@conferencepaper{conferencepaper, author={ÇAĞRI AKIN ŞEKERCİ Et Al. }, title={476 - The Value of Urinary BDNF Levels on Assessment of The Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia}, congress name={32nd Annual EAU Congress}, city={Londrina}, country={Brazil}, year={2017}, pages={823-824} }